Please use this identifier to cite or link to this item: http://repository.kln.ac.lk/handle/123456789/21119
Title: Differential expression of microRNA, miR-150 and Enhancer of Zeste Homolog 2 (EZH2) in peripheral blood cells as early prognostic markers of severe forms of dengue
Authors: Hapugaswatta, H.
Amarasena, P.
Premaratna, R.
Seneviratne, K.N.
Jayathilaka, N.
Keywords: microRNA
Issue Date: 2020
Publisher: Karger Medical and Scientific Publishers.
Citation: Journal of Biomedical Science. 2020;27(1):25.
Abstract: BACKGROUND: Dengue presents a wide clinical spectrum. Most patients recover following a self-limiting non-severe clinical course. A small proportion of patient’s progress to severe disease, mostly characterized by plasma leakage with or without hemorrhage. Early symptoms of severe dengue (SD) are similar to those of non-severe dengue fever (DF). Severe symptoms manifest after 3-5 days of fever, which can be life threatening due to lack of proper medications and inability to distinguish severe cases during the early stages. Early prediction of SD in patients with no warning signs who may later develop severe infection is very important for proper disease management to alleviate related complications and mortality. microRNA are small non-coding RNA molecules that regulate post-transcriptional gene expression. Due to the remarkable stability and the role of microRNA in gene expression, altered expression of microRNA was evaluated to explore clinically relevant prognostic markers of severe dengue. METHODS: The relative expression of microRNA hsa-let-7e (let-7e), hsa-miR-30b-5p (miR-30b), hsa-miR-30e-3p (miR-30e), hsa-miR-33a (miR-33a), and hsa-miR-150-5p (miR-150) and several putative target genes in peripheral blood cells (PBC) collected from 20 DF and 20 SD positive patients within 4 days from fever onset was evaluated by quantitative reverse transcription PCR (qRT-PCR). RESULTS: miR-150 showed significant (P < 0.01) up regulation in PBC of SD patients compared to DF patients during the acute phase of infection. Expression of enhancer of zeste homolog 2 (EZH2) was significantly (P < 0.01) down regulated indicating that genes involved in epigenetic regulation are also deferentially expressed in SD patients during the early stage of infection. CONCLUSIONS: Differential expression of microRNA miR-150 and the putative target gene EZH2 may serve as reliable biomarkers of disease severity during early stages of dengue infection. KEYWORDS: Acute dengue biomarkers; Dengue; Severe dengue; microRNA.
Description: Indexed in MEDLINE
URI: http://repository.kln.ac.lk/handle/123456789/21119
ISSN: 1021-7770 (Print)
1423-0127 (Electronic)
1021-7770 (Linking)
Appears in Collections:Journal/Magazine Articles

Files in This Item:
File Description SizeFormat 
Differential expression of microRNA.pdf694.07 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.